SCHEMBL15929208

SCHEMBL15929208

O=Cc1ccccc1OC(=O)CCC(=O)OCCCCO[N+](=O)[O-]

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.51
ALDH1A1 P00352 4/20 0.44
MAPT P10636 2/20 0.44
HPGD P15428 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HTT P42858 1/20 0.41
PTGS1 P23219 1/20 0.41
CA12 O43570 3/20 0.40
CA1 P00915 3/20 0.40
CA2 P00918 3/20 0.40
CA4 P22748 3/20 0.40
CA9 Q16790 3/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.39
NPC1 O15118 1/20 0.38
S1PR4 O95977 1/20 0.38
LMNA P02545 1/20 0.38
ITGA4 P13612 1/20 0.38
S1PR1 P21453 1/20 0.38
MAPK1 P28482 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2762555 0.91 PTGS2 (0.48) PTGS2ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL2763243 0.90 PTGS2 (0.47) PTGS2ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL2763284 0.90 PTGS2 (0.46) PTGS2ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL2762935 0.87 ALDH1A1 (0.47) PTGS2ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL14697091 0.83 PTGS2 (0.60) PTGS2ALDH1A1MAPTHPGDPTGS1
SCHEMBL15941304 0.81 ALDH1A1 (0.62) PTGS2ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL7358847 0.80 ALDH1A1 (0.61) PTGS2ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL5052278 0.79 ALDH1A1 (0.52) PTGS2ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL554351 0.79 PTGDR2 (0.50) PTGS2ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL9247222 0.79 ALDH1A1 (0.62) PTGS2ALDH1A1MAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450260-B2 NO- and H2S-releasing compounds RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) 2019-10-22 US disclosed
US-20170260124-A1 NO- AND H2S- RELEASING COMPOUNDS RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK 2017-09-14 US disclosed
US-20170260124-A1 NO- AND H2S- RELEASING COMPOUNDS RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK 2017-09-14 US disclosed
US-9688607-B2 No- and H2S-releasing compounds RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) 2017-06-27 US disclosed
US-9688607-B2 No- and H2S-releasing compounds RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) 2017-06-27 US disclosed
US-20140221316-A1 NO- AND H2S- RELEASING COMPOUNDS RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) 2014-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140221316-A1 NO- AND H2S- RELEASING COMPOUNDS PTGS1, NOS2, NOS1 PTGS2 4/4885ALDH1A1 363/4885MAPT 4769/4885
US-20170260124-A1 NO- AND H2S- RELEASING COMPOUNDS NOS2, NOS3, NOS1 PTGS2 9/4885ALDH1A1 961/4885MAPT 4419/4885
US-10450260-B2 NO- and H2S-releasing compounds NOS2, NOS3, NOS1 PTGS2 9/4885ALDH1A1 961/4885MAPT 4419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.